[
  {
    "ts": null,
    "headline": "Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity",
    "summary": "Pfizer (PFE) stock hold rating: 2026 patent cliff, falling Covid sales, GLP-1 obesity timeline, and M&A integration risksâread the outlook now.",
    "url": "https://finnhub.io/api/news?id=7f1e8732bb998309f0913b3ec2ddf9baf50127c0ac9ba0809869afaa01506c25",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770589155,
      "headline": "Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity",
      "id": 138398622,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2257390872/image_2257390872.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer (PFE) stock hold rating: 2026 patent cliff, falling Covid sales, GLP-1 obesity timeline, and M&A integration risksâread the outlook now.",
      "url": "https://finnhub.io/api/news?id=7f1e8732bb998309f0913b3ec2ddf9baf50127c0ac9ba0809869afaa01506c25"
    }
  }
]